 Connection
Charles Daley to Nebramycin
This is a "connection" page, showing publications Charles Daley has written about Nebramycin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.467 |
|
|
|
-
Nguyen MH, Plattner M, Verma D, Krishnamurthy RV, Xie M, Calado Nogueira de Moura V, Haldimann K, Lang R, Becker K, Kaur P, Shandil RK, Singh M, Bulman ZP, Dick T, Narayanan S, Schulthess B, Mitarai S, Daley CL, Hobbie SN. Multicentre preclinical profiling of apramycin for the treatment of nontuberculous mycobacteria. EBioMedicine. 2026 Jan; 123:106103.
Score: 0.239
-
Singh N, Dangi B, Johnson JJ, Louie A, Karunanidhi A, Curry BN, Mitarai S, Daley CL, Hobbie SN, Bulman ZP. Pharmacodynamic assessment of apramycin against Mycobacterium abscessus in a hollow fibre infection model. J Antimicrob Chemother. 2025 May 02; 80(5):1309-1314.
Score: 0.228
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|